1 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA
2 Cardiovascular Sciences Section, Baylor College of Medicine, Houston, TX 77030, USA
3 Center for Cardiovascular Development, Baylor College of Medicine, Houston, TX 77030, USA
4 Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
5 Yale Child Health Research Center, Yale University School of Medicine, New Haven, CN, USA
6 Department of Pathology, Mie University, School of Medicine, Tsu, Mie, Japan
* These authors contributed equally to this work
Author for correspondence (e-mail: schwartz{at}bcm.tmc.edu)
Accepted May 12, 2001
![]() |
SUMMARY |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Rho kinase, Y27632, Cardia bifida, Cardiomyocyte differentiation, Chick
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The mammalian Rho-associated kinase family (hereafter referred to as Rho kinases) is comprised of Rho kinase/ROK/ROCK2 and p160ROCK/ROCK1/ROKß (Ishizaki et al., 1996; Matsui et al., 1996). These serine/threonine protein kinases, identified as direct effectors of RhoA, are implicated in the regulation of cytoskeletal organization (Amano et al., 1997; Leung et al., 1996). They regulate myosin light chain (MLC) phosphorylation directly by phosphorylating MLC and by inactivating myosin phosphatase (Kimura et al., 1996). Phosphorylation of MLC induces smooth muscle contraction, formation of stress fibers and focal adhesions. Rho kinases also phosphorylate LIM kinase (Maekawa et al., 1999), ezrin/radixin/moesin proteins and adducin (Fukata et al., 1999), thereby regulating actin dynamics, cell adhesion, membrane ruffling and cell motility. Although there is considerable evidence that Rho kinases mediate many in vivo functions of RhoA, their roles in regulating embryonic morphogenesis remain unknown.
We asked whether Rho kinases play a morphogenetic role during the elaboration of embryonic tissues. A pyridine derivative, Y27632, was discovered to specifically inhibit the activity of Rho kinases (Uehata et al., 1997). Subsequently, this compound has been widely used to evaluate the roles of Rho kinases in a variety of systems (Sawada et al., 2000; Itoh et al., 1999; Kuwahara et al., 1999). Our studies demonstrate that Y27632 is a potent teratogen that blocked the migration of precardiac mesoderm and cardiac tube fusion in cultured chick and mouse embryos. Rho kinase inhibition by this compound also blocked brain and somite formation, and induced laterality defects. Treatment of chick embryos with Rho kinase antisense oligonucleotides also caused severe defects in head formation and cardiac tube fusion/looping. Last, our evidence indicates that Rho kinases may repress cardiac cell differentiation as their inhibition resulted in precocious activation of the cardiac -actin gene expression.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In vitro culture and drug treatment of chick and mouse embryos
Embryos were removed from fertilized White Leghorn eggs (A&M University, College Station, TX) incubated at 37°C and staged according to Hamburger and Hamilton (Hamburger and Hamilton, 1951). Embryos developed between stages 4 and 8 were placed inside of Watman paper rings and laid ventral side-up on albumin-agar plates (Sundin and Eichele, 1992). Y27632 compound diluted to 200 µM in Yolk-Tyrodes solution was added (20 µl) to the surface of the embryos. Embryos were then incubated in humidified 37°C incubator for 4-20 hours to reach developmental stages 8-12 and processed for whole-mount in situ hybridization as described below. Mouse embryos (C57BL/6) were cultured in the roller system, as described (Sturm and Tam, 1993). Embryos of 7.5 days post-coitum (E7.5) or E8.0 (five per 60 ml bottle) were cultured at 38°C for 48 hours in 5 ml of rat serum with or without Y27632 (10 µM) to reach E8.5-9.0 or E9.0-9.5, respectively. Because chick embryos were cultured on a semi-solid support and both the paper ring and the agar absorbed the compound, a higher concentration (200 µM) was required to induce developmental defects. However, mouse embryos were cultured in liquid medium; thus, a lower concentration of Y27632 (10 µM) was sufficient to produce similar defects.
Whole-mount in situ hybridization of chick and mouse embryos
Whole-mount in situ hybridization of chick embryos was carried out as described (Yamada et al., 1999). To examine the expression pattern of each Rho kinase isoform, three different antisense probes were synthesized from chick partial cDNAs and showed similar expression patterns. No signal was observed with sense probes (data not shown). One antisense probe was generated for each of the following genes: cardiac -actin (Hayward and Schwartz, 1986), GATA4 (Laverriere et al., 1994), GATA5 (Laverriere et al., 1994), serum response factor (SRF; Croissant et al., 1996), Nkx2.5 (Schultheiss et al., 1995), Irx4 (Bao et al., 1999), AMHC1 (Yutzey et al., 1994), Sonic hedgehog (Shh) and Nodal (Levin et al., 1995). After color development, 10 µM sections were cut from paraffin-embedded whole mounts of cardiac
-actin.
Whole-mount in situ hybridization of mouse embryos was carried out as described (Yamada et al., 1999). Partial mouse p160ROCK and ROK cDNA clones were obtained from ATCC (Rockville, Maryland) and sequences were confirmed by DNA sequencing. The cDNA of the mouse p160ROCK clone covers nucleotides 1244-1985 (Accession Number, U58512) and that of ROK
covers nucleotides 1458-3170 (Accession Number, U58513). Both antisense and sense probes were synthesized from these partial cDNAs, and no signal was observed with sense probes (data not shown). The Nkx2.5 antisense probe was generated from a cDNA containing full-length coding region (Lints et al., 1993).
Immunohistochemistry analysis
Mouse embryos were equilibrated in 20% sucrose in PBS, embedded in OCT compound (Tissue-Tek), frozen in dry ice and sectioned at 10 µm on a cryostat. Sections were fixed in 4% paraformaldehyde, incubated with anti--actinin (Sigma) at 1:500 dilution and then with biotin labeled anti-mouse IgG (Sigma) at 1:200 dilution. The secondary antibody was visualized with Vectastain ABC kit (Vector Laboratories).
Antisense oligonucleotide treatment
Two antisense oligonucleotides for Rho kinases and two randomized control oligonucleotides were used. Their sequences are: p160-AS (20-mers), 5'-ATTCCAAAGCTGCTTGCAGC-3'; ROK-AS (23-mers), 5'-TTCATGCAAGTGCCAAAATCTGC-3'; control oligo 1 (20-mers), 5'-GGTGGTCCGTACATAAGGTA-3'; control oligo 2 (23-mers), 5'-AAGTACGTTCACGGTTTTAGACG-3'. Control oligo 1 and oligo 2 have the same GC content as that of p160-AS and ROK
-AS, respectively. For each oligonucleotide, the first three and the last three bases were phosphorothioate modified. All oligonucleotides were applied as droplets of 20 µl at 20-40 µM concentration on top of the cultured chick embryos of stages 4-6. DMSO (1%) was added to the oligonucleotide solution to improve oligonucleotide penetration into cells. General toxicity effects were not apparent with oligonucleotide concentrations of 10 to 40 µM. Embryos were collected 4 hours later for RT-PCR analysis or were incubated for 20 hours (stage 12) for morphological analysis by whole-mount in situ hybridization with cardiac
-actin probe.
RT-PCR analysis
RNA was harvested from the treated or control embryos at different time points as indicated using TRIZOL (Gibco-BRL, Gaithersburg, MD). Each RNA sample was prepared from a pool of three identically treated embryos. First strand cDNA synthesis was carried out with the SuperScrit Preamplification System (Gibco-BRL) in a volume of 50 µl using 2.5 µg of RNA and 125 ng of Oligo (dT)12-18. PCR reaction was then carried out with 2 µl of first strand cDNA and one set of specific primers. For each primer set, two or three cycle numbers were tested to be certain that PCR product accumulated within a linear range. PCR reactions including trace amount of -32P[dCTP] were separated by 6% polyacrylamide gel electrophoresis and quantitated by PhosphorImage analysis. GAPDH (10 to 15 cycles) was amplified as a control marker with primers as described (Barron et al., 2000). Other genes were amplified each with a specific primer set: chick GATA4 (20 to 25 cycles), Nkx2.5 (15 to 20 cycles) and SRF (20 to 22 cycles; Barron et al., 2000); chick cardiac
-actin (20 to 25 cycles), forward 5'-TAAGCACTTTTCCCTACATT-3', reverse 5'-AAGCAATAAATATTAGAAGC-3'; chick p160ROCK (23 to 25 cycles), forward 5'-GATTTTGCCTCCTCTATTGAC-3', reverse 5'-GCTGCAAGCAGCTTTGGAATC-3'; chick ROK
(23 to 25 cycles), forward 5'-CAATGGAACGTGCAAGTTGTT-3', reverse 5'-CAGGAGAATAATCATCTTCAG-3'. Expression of each gene was then normalized to GAPDH.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In situ hybridization analysis in chick using ROK and p160ROCK probes showed that transcripts for both Rho kinase isoforms displayed a diffuse expression pattern before the appearance of the first somite (stage 6; Fig. 1A,E). They then became enriched in the head fold at the one-somite stage (stage 7) and in the developing neural system at four-somite stage (stage 8; Fig. 1B,C,F,G). p160ROCK was also enriched in somites and Hensens node, the organizer region involved in gastrulation and laterality (Fig. 1B,C). Both ROK
and p160ROCK were expressed in the neural ectoderm, and p160ROCK was also enriched in the lateral mesoderm, notochord and Hensens node (Fig. 1D,H).
|
Rho kinase inhibitor, Y27632, induced cardia bifida and severe neural defects in cultured chick and mouse embryos
To investigate the role of Rho kinases in early development, we treated cultured chick embryos with the selective Rho kinase inhibitor, Y27632. Strikingly, approximately 90% of the embryos first exposed to Y27632 between stages 4-6 formed two laterally positioned beating hearts (cardia bifida; Fig. 2B; Table 1). In the most severe cases, the heart tubes were well separated and located anteriorly in the embryos. In other cases, partial migration of the heart promordia was observed but the heart tubes did not fuse in the midline (see Fig. 4D). In addition, there was a stage-dependency of initial exposure to Y27632, as only 19% of embryos treated from stages 7-8 displayed cardia bifida and about 27% had fused heart tubes though with abnormal looping (Table 1). These results suggest that Rho kinases regulate the migration of the cardiac precursors to the ventral midline. In the most severe cases, neurulation was disrupted, resulting in either a poorly formed brain, or its complete absence, and the failure to form a closed neural tube (Fig. 2D). Somitogenesis was also disrupted as somites failed to condense, and in some cases, anterior somites appeared to be fractured into minisomites (see Fig. 5C). Thus, the cardiac, neural and somite developmental defects induced by Y27632 correlate with the expression pattern of ROK and p160ROCK in early chick embryos.
|
|
|
|
We then asked if other protein kinase inhibitors would elicit embryonic defects similar to those caused by Y27632. The affinity of Y27632 for Rho kinases is about 200 times greater than that for PKA and PKC (Uehata et al., 1997). We observed that neither H7 nor H9, protein kinase inhibitors with greater affinities for PKA and PKC than for Rho kinases, efficiently caused cardia bifida (Table 1). As Rho kinases regulate the phosphorylation state of MLC, we also asked if MLC phosphorylation was a target primarily responsible for the morphogenetic defects caused by Rho kinase inhibition. ML-9, a MLC kinase inhibitor, and calyculin A, a MLC phosphatase inhibitor, have previously been shown to affect smooth muscle cell contraction (Uehata et al., 1997); however, neither drug efficiently induced cardia bifida in chick embryos (Table 1). Thus, the cardiac teratology induced by Y27632 was neither primarily due to inhibition of MLC phosphorylation nor to the nonspecific inhibition of other protein kinases.
Y27632 induced midline structural and left-right asymmetry defects
In normal embryos, Hensens node regresses, driven by its caudal region (Charrier, et al., 1999), and leaves in its wake the notochord. The regression begins at stage 6 and reaches the end of the primitive streak by stage 10. Y27632 treatment beginning between stages 4-6 halted regression of Hensens node. Thus, the node remained anteriorly located; consequently, the posterior half of the embryo lacked Hensens node-derived structures including the notochord (Fig. 3A). Both Hensens node and the midline structure are crucial for the development of the left-right axis. An asymmetric signaling cascade is initiated from Hensens node during gastrulation, and the midline structure is thought to serve as a barrier maintaining the integrity of the left-right signaling cascade (Burdine and Schier, 2000). Nodal is asymmetrically expressed within the left lateral plate at stage 7, and this asymmetry remains until stage 11 in control embryos. Interestingly, in embryos treated with Y27632 from stages 4-6, Nodal was bilaterally expressed (Fig. 3B), indicating a central role for Rho kinases in left-right axis formation.
|
Y27632 upregulated cardiac gene activity and expanded the paired heart fields
In addition to their midline migration, specified cells in the paired cardiac fields undergo terminal differentiation. In chick embryos, borders of the heart fields can be determined by expression of Nkx2.5 and GATA4 at stage 5 (Chen and Fishman, 2000), while markers of terminal differentiation such as cardiac -actin become detectable at stage 8. To analyze myocardial differentiation in Y27632 treated embryos, we examined the expression of cardiac
-actin, GATA4, SRF and Nkx2.5. In stage 8 embryos, cardiac
-actin expression was significantly upregulated (about threefold) by Y27632, indicating precocious activation of the cardiac
-actin gene, coincident with the posterior expansion of GATA4 expression (Fig. 5A,B). As SRF and GATA-4 transcripts in stage 8 embryos were also increased four- to fivefold by Y27632 (Fig. 5E), they may be partly responsible for precociously activating SRF-dependent cardiac
-actin expression in the expanded heart fields. By stage 12, no significant difference in the expression levels of these cardiac genes was observed between Y27632 treated and control embryos as the developing hearts reached terminal differentiation (Fig. 5E). Thus, Rho kinases regulate the appropriate onset of myocardial differentiation.
Anteroposterior polarity of the heart is partially conserved in Y27632-treated chick embryos
During early cardiogenesis, the anterior region of the paired heart fields becomes the developing ventricles whereas the posterior region becomes the developing atria upon fusion into a definitive heart tube. To analyze whether this anteroposterior pattern was affected in the unfused heart tubes of Y27632-treated chick embryos, we examined the expression of a ventricle-specific marker, Irx4, and an atrial-specific marker, AMHC1. Irx4 and AMHC1 expression patterns do not overlap in control embryos (Fig. 5F). In Y27632-treated chick embryos, the expression of Irx4 was more enriched in the anterior regions but was expanded to the posterior regions of the heart tubes, whereas AMHC1 was more restricted to the posterior regions of each heart tube (Fig. 5F). In addition, GATA4 transcripts were also restricted to the posterior region of the heart tubes in the drug-treated embryos (Fig. 5B). During stages 5-7, the cardiogenic mesoderm cells in the paired heart fields undergo a directed craniomedial migration and meet in the midline over the developing head fold to form a cardiogenic crescent. The posterior expansion of Irx4 expression was probably due to defects in craniomedial migration of the anterior precardiac cells. The restricted posterior expression patterns of AMHC1 and GATA4 in Y27632-treated embryos suggested that cardiomyogenic lineage diversification was not affected.
Application of antisense oligonucleotides reproduced Y27632 induced embryonic defects
We used a complementary approach to analyze the function of Rho kinases in embryogenesis through their mRNA depletion using antisense oligonucleotides. Two antisense oligonucleotides (p160-AS and ROK-AS) were specifically designed each to target its respective Rho kinase isoform. They both decreased the mRNA level of their targeted isoform up to 50%, while two random control oligonucleotides had no significant effect relative to non-oligo controls (Fig. 6A). While ROK
-AS has some homology (two mismatches) to the p160ROCK sequence, p160-AS has no homology to the ROK
sequence. However, both p160-AS and ROK
-AS reduced the mRNA level of their non-targeted cognate isoform, suggesting a potential positive feedback mechanism for transcriptional regulation of Rho kinases. Thus, the expression of one isoform seems to maintain the expression of the other isoform and vice-versa. Interestingly, cardiac
-actin expression was upregulated, whereas Nkx2.5 expression remained unchanged (Fig. 6A). This is consistent with precocious activation of the cardiac
-actin gene in Y27632-treated chick embryos. Morphological defects like those associated with the drug inhibition of Rho kinases were also observed in chick embryos treated with antisense oligonucleotides (i.e. cardia bifida, abnormal looping of the heart tube, abnormal head and somite formation; Fig. 6B,C). The incidence of abnormal embryos as well as the severity of the defects (in cardia bifida, the independently beating heart tubes were very close) was comparable with that induced by Y27632 at a lower concentration (Table 1). This may be due to the partial depletion of Rho kinase mRNA and the pre-existing Rho kinase protein, which may persist.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Previous studies have shown that ectopic addition of retinoic acid (Sundin and Eichele, 1992; Osmond et al., 1991) or depletion of GATA4 or GATA5 (Jiang et al., 1998; Molkentin et al., 1997; Kuo et al., 1997; Reiter et al., 1999) disrupted precardiac mesoderm migration resulting in cardia bifida. Could these factors mediate the morphogenetic actions of Rho kinases in embryogenesis? As Hensens node regressed normally in chick embryos treated with retinoic acid (Sundin and Eichele, 1992; Osmond et al., 1991), it is likely that different mechanisms mediate the effects of Rho kinases versus retinoic acid on embryogenesis. Moreover, GATA4 (Fig. 5B) was expressed in Y27632-treated embryos at higher levels than in control embryos, suggesting that the effects of Rho kinases are not mediated by a deficit of this transcription factor. Studies in chick, mouse and zebrafish embryos have indicated that cardia bifida may be secondary to endoderm defects (Narita et al., 1997; Alexander et al., 1999; Reiter et al., 1999). GATA5, a mesoderm and endoderm differentiation marker, was expressed in both endoderm and mesoderm of drug-treated embryos (Fig. 4), indicating that cardia bifida did not result from a lack of endoderm differentiation. However, the possibility that the underlying endoderm is unable to provide a permissive environment for the migration of precardiac cells in drug-treated embryos can not be excluded. However, a recent study in zebrafish has shown that cardia bifida was induced by mutation of the sphingosine-1-phosphate (S1P) receptor (Kupperman et al., 2000), a G-protein-coupled receptor that activates several downstream signaling molecules including RhoA. As Rho kinases function downstream of RhoA, effects of S1P receptor-mediated signaling on precardiac cell migration may be mediated in part by Rho kinases.
Our study also shows that Rho kinases are involved in preventing cardiomyocyte differentiation. Precocious activation of cardiac -actin observed in Rho kinase inhibitor and antisense oligonucleotide-treated embryos suggests that Rho kinases may be required to prevent terminal myocyte differentiation before fusion of the paired heart tubes occurs. During early embryogenesis, signals inhibiting cardiac differentiation are thought to originate from within the precardiac mesoderm and also from dorsal/medial structures, including the neural plate, neural fold and notochord (Chen and Fishman, 2000). As neural development is also severely affected by the inhibition of Rho kinases, inhibitory signals from neural tissues could also be attenuated and in part cause precocious cardiomyocyte differentiation. It is worth noting that Rho kinase inhibitor-induced precocious activation of cardiac
-actin may be partly responsible for abnormal migration of the precardiac mesoderm. Previous studies on the actin family show that the striated cardiac and skeletal
-actins compose contractile sarcomeres and smooth muscle
and
-actins form smooth muscle myofibrils, whereas the ubiquitous ß- and
-cytoplasmic actins are involved in cell motility (Vandekerckhove and Weber, 1978). The functional roles of these actin isoforms are not equivalent (Schildmeyer et al., 2000). Thus, precocious activation of cardiac
-actin might promote formation of sarcomeric structure that could impair myocyte motility.
The mechanism by which Rho kinases suppress cardiac -actin (and perhaps other cardiac specific) gene expression in precardiac cells may play a central role in heart development. Rho kinase signaling may be mediated indirectly through the actin cytoskeleton, which has been shown to mediate Rho kinase-dependent gene expression (Hahn et al., 2000; Iwamoto et al., 2000). Rho kinases may also regulate cardiac
-actin gene activity directly through transcription factors like SRF. We have observed that SRF is an in vitro and in vivo substrate for Rho kinases and that phosphorylation of SRF blocks its DNA-binding activity, thus repressing SRF-dependent cardiac
-actin promoter activation (D. Iyer, L. W., N. S. Belaguli, T. Otani, A. Balasubramanyam and R. J. S., unpublished). We have previously reported that SRF cooperates with GATA4 to synergistically activate numerous muscle-specific or non-muscle promoters containing serum response elements including cardiac
-actin and SRF itself (Belaguli et al., 2000). Interestingly, precocious activation of the cardiac
-actin gene in Y27632-treated embryos is associated with up-regulation of GATA4 and SRF expression, suggesting that increased expression of SRF and GATA4 may be responsible in part for activation of cardiac
-actin gene transcription.
In summary, we have demonstrated that Rho kinases regulate various vertebrate embryonic morphogenetic events, including cell migration, cell differentiation and axis formation. These observations reveal new biological functions for Rho kinases in early embryogenesis, particularly cardiac organogenesis. In addition, the present study indicates that Y27632, a potential therapeutic drug for the treatment of hypertension, vascular proliferative disorders and cancer (Uehata et al., 1997; Sawada et al., 2000; Itoh et al., 1999; Kuwahara et al., 1999), is also a powerful teratogenic agent. Information regarding the teratogenic effects of this compound will be useful in designing clinical trials of this and other Rho kinase inhibitors.
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Alexander, J., Rothenberg, M., Henry, G. L. and Stainier, D. Y. (1999) Casanova plays an early and essential role in endoderm formation in zebrafish. Dev. Biol. 215, 343-357[Medline]
Amano, M., Chihara, K., Kimura, K., Fukata, Y., Nakamura, N., Matsuura, Y. and Kaibuchi, K. (1997) Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 275, 1308-1311.
Arber, S., Barbayannis, F. A., Hanser, H., Schneider, C., Stanyon, C. A., Bernard, O. and Caroni, P. (1998) Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393, 805-809.[Medline]
Bao, Z. Z., Bruneau, B. G., Seidman, J. G., Seidman, C. E. and Cepko, C. L. (1999) Regulation of chamber-specific gene expression in the developing heart by Irx4. Science 283, 1161-1164.
Barrett, K., Leptin, M. and Settleman, J. (1997) The Rho GTPase and a putative RhoGEF mediate a signaling pathway for the cell shape changes in Drosophila gastrulation. Cell 91, 905-915.[Medline]
Barron, M., Gao, M. and Lough, J. (2000) Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Dev. Dyn. 218, 383-393.[Medline]
Belaguli, N. S., Sepulveda, J. L., Nigam, V., Charron, F., Nemer, M., Schwartz, R. J. (2000) Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators. Mol. Cell. Biol. 20, 7550-7558.
Burdine, R. D. and Schier, A. F. (2000) Conserved and divergent mechanisms in left-right axis formation. Genes Dev. 14, 763-776.
Charrier, J. B., Teillet, M. A., Lapointe, F. and Le Douarin, N. M. (1999) Defining subregions of Hensens node essential for caudalward movement, midline development and cell survival. Development 126, 4771-4783.
Chen, J. N. and Fishman, M. C. (2000) Genetics of heart development. Trends. Genet. 16, 383-388.[Medline]
Cheng, A. K. and Robertson, E. J. (1995) The murine LIM-kinase gene (limk) encodes a novel serine threonine kinase expressed predominantly in trophoblast giant cells and the developing nervous system. Mech. Dev. 52,187-197.[Medline]
Croissant, J. D., Kim, J. H., Eichele, G., Goering L., Lough, J., Prywes, R and Schwartz, R. J. (1996) Avian serum response factor expression restricted primarily to muscle cell lineages is required for alpha-actin gene transcription. Dev. Biol. 177, 250-264.[Medline]
Fukata, Y., Oshiro, N. and Kaibuchi, K. (1999) Activation of moesin and adducin by Rho-kinase downstream of Rho. Biophys. Chem. 82, 139-147.[Medline]
Hahn, A., Heusinger-Ribeiro, J., Lanz, T., Zenkel, S. and Goppelt-Struebe, M. (2000) Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton. J. Biol. Chem. 275, 37429-37435.
Hall, A. (1994) Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu. Rev. Cell Biol. 10, 31-54.
Hamburger, V. and Hamilton, H. L. (1951) A series of normal stages in the development of the chick embryos. J. Morphol. 88, 49-92.
Hayward, L. J. and Schwartz, R. J. (1986) Sequential expression of chicken actin genes during myogenesis. J. Cell Biol. 102, 1485-1493.[Abstract]
Ishizaki, T., Maekawa, M., Fujisawa, K., Okawa, K., Iwamatsu, A., Fujita, A., Watanabe, N., Saito, Y., Kakizuka, A., Morii, N. and Narumiya, S. (1996) The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J. 15, 1885-1893.[Abstract]
Itoh, K., Yoshioka, K, Akedo, H., Uehata, M., Ishizaki, T. and Narumiya, S. (1999) An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat. Med. 5, 221-225.[Medline]
Iwamoto, H., Nakamuta, M., Tada, S., Sugimoto, R., Enjoji, M. and Nawata, H. (2000) A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth. J. Hepatol. 32, 762-770.[Medline]
Jiang, Y., Tarzami, S., Burch, J. B. and Evans, T. (1998) Common role for each of the cGATA-4/5/6 genes in the regulation of cardiac morphogenesis. Dev. Genet. 22, 263-277.[Medline]
Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, B., Feng, J., Nakano, T., Okawa, K., Iwamatsu, A. and Kaibuchi, K. (1996) Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273, 245-248.[Abstract]
Kuo, C. T., Morrisey, E. E., Anandappa, R., Sigrist, K., Lu, M. M., Parmacek, M. S., Soudais, C. and Leiden, J. M. (1997) GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 11, 1048-1060[Abstract]
Kupperman, E., An, S., Osborne, N., Waldron, S. and Stainier, D. Y. (2000) A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development. Nature 406, 192-195.[Medline]
Kuwahara, K., Saito, Y., Nakagawa, O., Kishimoto, I., Harada, M., Ogawa, E, Miyamoto, Y., Hamanaka, I., Kajiyama, N., Takahashi, N., Izumi, T., Kawakami, R., Tamura, N., Ogawa, Y. and Nakao, K. (1999) The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytespossible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy. FEBS Lett. 452, 314-318.[Medline]
Laverriere, A. C., MacNeill, C., Mueller, C., Poelmann, R. E., Burch, J. B. and Evans, T. (1994) GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. J. Biol. Chem. 269, 23177-23184.
Leung, T., Chen, X. Q., Manser, E. and Lim, L. (1996) The p160 RhoA-binding kinase ROK is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol. Cell. Biol. 16, 5313-5327.[Abstract]
Levin, M., Johnson, R. L., Stern, C. D., Kuehn, M. and Tabin C. (1995) A molecular pathway determining left-right asymmetry in chick embryogenesis. Cell 82, 803-814.[Medline]
Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I. and Harvey, R. P. (1993) Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 119, 419-431.
Lyons, G. E. Vertebrate heart development. Curr. Opin. Genet. Dev. 6, 454-460 (1996).[Medline]
Maekawa, M., Ishizaki, T., Boku, S., Watanabe, N., Fujita, A., Iwamatsu, A., Obinata, T., Ohashi, K., Mizuno, K. and Narumiya, S. (1999) Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285, 895-898.
Magie, C. R., Meyer, M. R., Gorsuch, M. S. and Parkhurst, S. M. (1999) Mutations in the Rho1 small GTPase disrupt morphogenesis and segmentation during early Drosophila development. Development 126, 5353-5364.
Matsui, T., Amano, M., Yamamoto, T., Chihara, K., Nakafuku, M., Ito, M., Nakano, T., Okawa, K., Iwamatsu, A. and Kaibuchi, K. (1996) Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 15, 2208-2216.[Abstract]
Molkentin, J. D., Lin, Q., Duncan, S. A. and Olson, E. N. (1997) Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 11, 1061-1072.[Abstract]
Narita, N., Bielinska, M. and Wilson, D. B. (1997) Wild-type endoderm abrogates the ventral developmental defects associated with GATA-4 deficiency in the mouse. Dev. Biol. 189, 270-274[Medline]
Osmond, M. K., Butler, A. J., Voon, F. C. and Bellairs, R. (1991) The effects of retinoic acid on heart formation in the early chick embryo. Development 113, 1405-1417.[Abstract]
Reiter, J. F., Alexander, J., Rodaway, A., Yelon, D., Patient, R., Holder, N. and Stainier, D. Y. (1999) Gata5 is required for the development of the heart and endoderm in zebrafish. Genes Dev. 13, 2983-2995.
Sawada, N., Itoh, H., Ueyama, K., Yamashita, J., Doi, K., Chun, T. H., Inoue, M., Masatsugu, K., Saito, T., Fukunaga, Y., Sakaguchi, S., Arai, H., Ohno, N., Komeda, M. and Nakao, K. (2000) Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation 101, 2030-2033.
Schildmeyer, L. A., Braun, R., Taffet, G., Debiasi, M., Burns, A. E., Bradley, A. and Schwartz, R. J. (2000) Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse. FASEB J. 14, 2213-2220.
Schultheiss, T. M., Xydas, S. and Lassar, A. B. (1995) Induction of avian cardiac myogenesis by anterior endoderm. Development 121, 4203-4214.
Strutt, D. I., Weber, U. and Mlodzik, M. (1997) The role of RhoA in tissue polarity and Frizzled signalling. Nature 387, 292-295.[Medline]
Sturm, K. and Tam, P. P. (1993) Isolation and culture of whole postimplantation embryos and germ layer derivatives. Methods Enzymol. 225, 164-190.[Medline]
Sundin, O. and Eichele, G. (1992) An early marker of axial pattern in the chick embryo and its respecification by retinoic acid. Development 114, 841-852.[Abstract]
Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M. and Narumiya, S. (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990-994.[Medline]
Van Aelst, L. and DSouza-Schorey, C. (1997) Rho GTPases and signaling networks. Genes Dev. 11, 2295-2322.
Vandekerckhove, J. and Weber, K. (1978) At least six different actins are expressed in a higher mammal: an analysis based on the amino acid sequence of the amino-terminal tryptic peptide. J. Mol. Biol. 126, 783-802.[Medline]
Wunnenberg-Stapleton, K., Blitz, I. L., Hashimoto, C. and Cho, K. W. (1999) Involvement of the small GTPases XRhoA and XRnd1 in cell adhesion and head formation in early Xenopus development. Development 126, 5339-5351.
Yamada, M., Szendro, P. I., Prokscha, A. and Schwartz, R. J. and Eichele, G. (1999) Evidence for a role of Smad6 in chick cardiac development. Dev. Biol. 215, 48-61.[Medline]
Yutzey, K. E., Rhee, J. T. and Bader, D. (1994) Expression of the atrial-specific myosin heavy chain AMHC1 and the establishment of anteroposterior polarity in the developing chicken heart. Development 120, 871-883.